Evaluation of piperine analogs against prostate cancer targeting AKT1 kinase domain through network pharmacological analysis

被引：1
|
作者：
Nayana Prakash
机构：
[1] Kuvempu University,Department of PG Studies and Research in Biotechnology
来源：
In Silico Pharmacology | / 11卷 / 1期
关键词：
Piperine; Akt1; preADMET; pip2; In silico methods; AutoDock Vina;
D O I：
10.1007/s40203-023-00145-5
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 37 条
  • [1] Investigating the structural basis of piperine targeting AKT1 against prostate cancer through in vitro and molecular dynamics simulations
    Nayana, Prakash
    Gollapalli, Pavan
    Manjunatha, Hanumanthappa
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [2] A combined in vitro and molecular dynamics simulation studies unveil the molecular basis of the anticancer potential of piperine targeting AKT1 against prostate cancer
    Nayana, Prakash
    Manjunatha, Hanumanthappa
    Gollapalli, Pavan
    Ashok, Avinash Karkada
    Andrade, Preema Karal
    Vijayalaksmi, V.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (07): : 3616 - 3629
  • [3] MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1
    Qu, H. -W.
    Jin, Y.
    Cui, Z. -L.
    Jin, X. -B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) : 6252 - 6259
  • [4] Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1
    Han Zhang
    Fei Xie
    Xiao-ya Yuan
    Xin-tong Dai
    Yun-feng Tian
    Ming-ming Sun
    Si-qi Yu
    Jia-you Cai
    Bin Sun
    Wei-cheng Zhang
    Chang-liang Shan
    Acta Pharmacologica Sinica, 2024, 45 : 1044 - 1059
  • [5] Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1
    Zhang, Han
    Xie, Fei
    Yuan, Xiao-ya
    Dai, Xin-tong
    Tian, Yun-feng
    Sun, Ming-ming
    Yu, Si-qi
    Cai, Jia-you
    Sun, Bin
    Zhang, Wei-cheng
    Shan, Chang-liang
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (05) : 1044 - 1059
  • [6] Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer
    Armstrong, Lee
    Willoughby, Colin E.
    Mckenna, Declan J.
    CELLS, 2023, 12 (18)
  • [7] Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer
    Huo, Xiao
    Sun, Hengzi
    Liu, Qian
    Ma, Xiangwen
    Peng, Peng
    Yu, Mei
    Zhang, Ying
    Cao, Dongyan
    Shen, Keng
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [8] Targeting HSP90 Inhibits Proliferation and Induces Apoptosis Through AKT1/ERK Pathway in Lung Cancer
    Niu, Mengyuan
    Zhang, Bin
    Li, Li
    Su, Zhonglan
    Pu, Wenyuan
    Zhao, Chen
    Wei, Lulu
    Lian, Panpan
    Lu, Renwei
    Wang, Ranran
    Wazir, Junaid
    Gao, Qian
    Song, Shiyu
    Wang, Hongwei
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [9] Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial–mesenchymal transition in prostate cancer
    Mei Yang
    Hui Liu
    Guo-Ping Qiu
    Fei Gao
    Medical Oncology, 2022, 39
  • [10] Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer
    Yang, Mei
    Liu, Hui
    Qiu, Guo-Ping
    Gao, Fei
    MEDICAL ONCOLOGY, 2022, 39 (01)
1234